SRT1720
There’s been a bit of talk recently about a new drug, at the moment code-named SRT1720, that is essentially a version of resveratrol that is around the order of 1,000 times more active.
SRT1720 is initially being purported as a treatment for diabetes as it affects glucose metabolism, but its real promise in my and many others’ opinions is its life-extension potential.
I won’t bother reiterating the coverage at this point, rather directing you to a couple of articles that have emerged over the past few days: